Symbols

CLBT

Cellebrite DI·NASDAQ

--(--)

CLBT fundamentals

CLBT Q4 2025 Earnings

Cellebrite DI (CLBT) released its earnings on Feb 11, 2026: revenue was 128.82M (YoY +18.13%), beat estimates; EPS was 0.08 (YoY 0.00%), missed estimates.

Revenue / YoY

128.82M

+18.13%

EPS / YoY

0.08

0.00%

Report date

Feb 11, 2026

CLBT Earnings Call Summary for Q4,2025

Record ARR Growth: 21% YoY to $481M, driven by SaaS/cloud solutions (50%+ ARR growth) and Corellium acquisition.
2026 Guidance: 18-19% ARR growth, 19-20% revenue growth, and 26-27% EBITDA margin.
Strategic Acquisitions: SCG Canada for drone forensics ($15-20M price) and Corellium integration on track.
Federal Recovery: U.S. Federal unit to exceed company-wide growth, with 9PB storage contract in pipeline.
AI Innovation: Developing agentic applications for cold case investigations, targeting 2026 monetization.
Free Cash Flow: 34% margin in 2025, >30% in 2026.

Earnings

EPS

Revenue

Revenue & Expenses

CLBT has released its 2025 Q4 earnings report, with revenue of 128.82M, reflecting a YoY change of 18.13%, and net profit of 21.26M, showing a YoY change of 10.34%. The Sankey diagram below clearly presents CLBT's revenue sources and cost distribution.

Key Indicators

Cellebrite DI (CLBT) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Cellebrite DI (CLBT)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Cellebrite DI (CLBT)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Cellebrite DI (CLBT)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown